Option Care Health, Inc. OPCH
Set alert
At close · Oct 30
After hours · Oct 30, 4:15 PM ET
- YTD
- -0.09%
- 1 year
- +21.44%
- Open
- 31.85
- Prev close
- 31.85
- Mkt cap
- 4.77B
- Vol
- 4.23M
- Avg vol
- 3.90M
- EPS
- 1.32
- P/E
- 24.11
- Div yield
- 0.00%
More statistics
- Low
- 31.78
- High
- 31.90
- Forward P/E
- 15.28
- Beta
- 0.58
- Short ratio
- 1.06
- Inst. own
- 108.86%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 26.34
- 200-d avg
- 26.34
- 1y target
- 30.03
2Y chart
Events in this range
- Jul 30, 2025Earnings: 0.41; estimate 0.4; surprise 2.5%
- Oct 30, 2025Earnings: 0.45; estimate 0.43; surprise 4.65%
- Feb 24, 2026Earnings: 0.46; estimate 0.46; surprise 0%
- Apr 30, 2026Earnings: 0.4; estimate 0.37; surprise 8.11%
- Jul 29, 2026Earnings: 0.45; estimate 0.4263; surprise 5.56%
- Oct 7, 2026Downgrade: Barrington Research · Outperform → Market Perform
- Oct 7, 2026Downgrade: Jefferies · Buy → Hold
- Oct 7, 2026Downgrade: Citizens · Market Outperform → Market Perform
- Oct 7, 2026Downgrade: JP Morgan · Overweight → Neutral
- Oct 7, 2026Downgrade: William Blair · Outperform → Market Perform
- Oct 9, 2026Downgrade: UBS · Buy → Neutral
Signals (87)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 26, 2026 | 5 days ago |
| SMA: Bullish | Oct 6, 2026 | 3 weeks ago |
| SMA: Bullish | Oct 6, 2026 | 3 weeks ago |
| MACD: Buy Signal | Oct 6, 2026 | 3 weeks ago |
| RSI: Overbought | Oct 6, 2026 | 3 weeks ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 21, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| MACD: Buy Signal | Jul 27, 2026 | 3 months ago |
| SMA: Bullish | Jul 24, 2026 | 3 months ago |
| SMA: Bearish | Jul 23, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 22, 2026 | 3 months ago |
| SMA: Bullish | Jul 7, 2026 | 3 months ago |
| SMA: Bearish | Jul 6, 2026 | 3 months ago |
| SMA: Bullish | Jul 2, 2026 | 4 months ago |
| MACD: Buy Signal | May 19, 2026 | 5 months ago |
| RSI: Oversold | Apr 30, 2026 | 6 months ago |
| MACD: Sell Signal | Apr 29, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 6, 2026 | 6 months ago |
| RSI: Oversold | Mar 19, 2026 | 7 months ago |
| RSI: Oversold | Mar 6, 2026 | 7 months ago |
| SMA: Bearish | Mar 5, 2026 | 8 months ago |
| SMA: Bearish | Feb 24, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 24, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 18, 2026 | 8 months ago |
| SMA: Bullish | Feb 11, 2026 | 8 months ago |
| SMA: Bearish | Feb 10, 2026 | 8 months ago |
| MACD: Sell Signal | Jan 28, 2026 | 9 months ago |
| MACD: Buy Signal | Jan 14, 2026 | 9 months ago |
| RSI: Overbought | Jan 13, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 22, 2025 | 10 months ago |
| RSI: Overbought | Dec 9, 2025 | 10 months ago |
| SMA: Bullish | Dec 8, 2025 | 10 months ago |
| SMA: Bearish | Dec 3, 2025 | 11 months ago |
| SMA: Bullish | Nov 25, 2025 | 11 months ago |
| RSI: Overbought | Nov 25, 2025 | 11 months ago |
| SMA: Bullish | Nov 10, 2025 | 11 months ago |
| MACD: Buy Signal | Nov 10, 2025 | 11 months ago |
| MACD: Sell Signal | Oct 31, 2025 | 1 year ago |
| SMA: Bearish | Oct 30, 2025 | 1 year ago |
| SMA: Bullish | Oct 28, 2025 | 1 year ago |
| SMA: Bearish | Oct 24, 2025 | 1 year ago |
| SMA: Bullish | Oct 20, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 16, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 23, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 22, 2025 | 1 year ago |
| MACD: Sell Signal | Sep 16, 2025 | 1 year ago |
| SMA: Bearish | Sep 12, 2025 | 1 year ago |
| SMA: Bullish | Sep 11, 2025 | 1 year ago |
| SMA: Bearish | Sep 9, 2025 | 1 year ago |
| SMA: Bullish | Sep 8, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 14, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 1, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 29, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 3, 2025 | 1 year ago |
| SMA: Bearish | Jul 1, 2025 | 1 year ago |
| SMA: Bullish | Jun 27, 2025 | 1 year ago |
| SMA: Bearish | Jun 25, 2025 | 1 year ago |
| SMA: Bullish | Jun 24, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 24, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 18, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 17, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 11, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 10, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 2, 2025 | 1 year ago |
| MACD: Buy Signal | May 30, 2025 | 1 year ago |
| MACD: Sell Signal | May 23, 2025 | 1 year ago |
| SMA: Bullish | May 16, 2025 | 1 year ago |
| MACD: Buy Signal | May 15, 2025 | 1 year ago |
| MACD: Sell Signal | May 13, 2025 | 1 year ago |
| SMA: Bearish | May 8, 2025 | 1 year ago |
| SMA: Bullish | May 7, 2025 | 1 year ago |
| MACD: Buy Signal | May 2, 2025 | 1 year ago |
| SMA: Bearish | Apr 11, 2025 | 1 year ago |
| SMA: Bullish | Apr 9, 2025 | 1 year ago |
| SMA: Bearish | Apr 7, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 28, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 25, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 7, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 4, 2025 | 1 year ago |
| RSI: Overbought | Feb 25, 2025 | 1 year ago |
| RSI: Overbought | Feb 18, 2025 | 1 year ago |
| RSI: Overbought | Feb 10, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 5, 2025 | 1 year ago |
| RSI: Overbought | Jan 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 6, 2025 | 1 year ago |
Key statistics
- Market cap
- 4.77B
- Enterprise value
- 5.84B
- Trailing P/E
- 24.11
- Forward P/E
- 15.28
- PEG ratio
- 1.53
- Price / sales
- 0.84
- Price / book
- 3.78
- EPS (TTM)
- 1.32
- Beta
- 0.58
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 3.68%
- Revenue (TTM)
- 5.69B
- Revenue growth
- 1.90%
- Free cash flow
- 256.07M
- Total cash
- 196.78M
- Total debt
- 1.27B
- Return on equity
- 16.00%
- Shares outstanding
- 149.79M
- Short % of float
- 6.62%
- 50-day average
- 26.34
- 200-day average
- 26.34
Analyst view
Consensus: hold
- Target (low)
- 23.00
- Target (mean)
- 30.03
- Target (high)
- 33.00
- Strong buy0
- Buy0
- Hold11
- Sell0
- Strong sell0
Next earnings
Nov 4, 2026
Expected Nov 4, 2026. Consensus EPS estimate 0.48713.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 4, 2026 | Sep 30, 2026 | 0.4894 | — | — | — |
| Jul 29, 2026 | Jun 30, 2026 | 0.4263 | 0.45 | +0.02 | +5.56% |
| Apr 30, 2026 | Mar 31, 2026 | 0.37 | 0.40 | +0.03 | +8.11% |
| Feb 24, 2026 | Dec 31, 2025 | 0.46 | 0.46 | 0.00 | 0.00% |
| Oct 30, 2025 | Sep 30, 2025 | 0.43 | 0.45 | +0.02 | +4.65% |
| Jul 30, 2025 | Jun 30, 2025 | 0.40 | 0.41 | +0.01 | +2.50% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 9, 2026 | UBS | down | Buy | Neutral |
| Oct 7, 2026 | William Blair | down | Outperform | Market Perform |
| Oct 7, 2026 | JP Morgan | down | Overweight | Neutral |
| Oct 7, 2026 | Citizens | down | Market Outperform | Market Perform |
| Oct 7, 2026 | Jefferies | down | Buy | Hold |
| Oct 7, 2026 | Barrington Research | down | Outperform | Market Perform |
About Option Care Health, Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failure; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as Duchenne muscular dystrophy, multiple sclerosis, Alzheimer's disease, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. The company is headquartered in Bannockburn, Illinois.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Country
- United States
- Website
- optioncarehealth.com
News
- OPCH Stock Alert: Halper Sadeh LLC is Investigating Whether Option Care Health, Inc. is Obtaining a Fair Price for its Shareholders
- Are BRZE, SLN, OPCH, RXO Obtaining Fair Deals for their Shareholders?
- BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Silence Therapeutics plc (Nasdaq – SLN), Option Care Health, Inc. (Nasdaq – OPCH), RXO Inc. (NYSE – RXO), Sangoma Technologies Corporation (Nasdaq – SANG)
- Are DSGR, OPCH, PRTH, UTZ Obtaining Fair Deals for their Shareholders?
- Are DSGR, OPCH, PRTH, UTZ Obtaining Fair Deals for their Shareholders?
- Cencora (NYSE:COR) and Option Care Health (NASDAQ:OPCH) Financial Contrast
- Top 3 Health Care Stocks That May Fall Off A Cliff In October
- OPCH Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Proposed Sale of Option Care Health to CD&R and McKesson
- Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
- Are OPCH, PCRX, RXO, BOLD Obtaining Fair Deals for their Shareholders?
Your note
Sign in to keep a note on OPCH — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BHATIA PRATEEK | Officer | Stock Award(Grant) | Jul 5, 2026 | 39,795 |
| GOLDING DAVID W | Director | Purchase | Aug 20, 2025 | 116,525 |
| GRASHOFF CHRISTOPHER L | Officer | Stock Award(Grant) | Feb 17, 2026 | 48,558 |
| KRAEMER HARRY M. JANSEN JR. | Director | Stock Award(Grant) | May 19, 2026 | 471,076 |
| RADEMACHER JOHN CHARLES | Chief Executive Officer | Purchase | May 3, 2026 | 695,152 |
| SETHNA MEENAL | Chief Financial Officer | Purchase | May 3, 2026 | 98,337 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 14.76% | 22,104,863 | 703.60M | Jun 29, 2026 |
| Wellington Management Group, LLP | 7.87% | 11,782,384 | 375.03M | Jun 29, 2026 |
| Vanguard Portfolio Management LLC | 5.52% | 8,274,458 | 263.38M | Jun 29, 2026 |
| Fuller & Thaler Asset Management Inc. | 4.97% | 7,450,698 | 237.16M | Jun 29, 2026 |
| Vanguard Capital Management LLC | 4.72% | 7,063,747 | 224.84M | Jun 29, 2026 |
| Durable Capital Partners Lp | 4.12% | 6,163,722 | 196.19M | Jun 29, 2026 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Capitol Series Trust-FullerThaler Behavioral Small-Cap Equity Fund | 4.78% | 7,157,244 | 227.82M | Jun 29, 2026 |
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 4.51% | 6,748,598 | 214.81M | Jul 30, 2026 |
| iShares Trust-iShares Core S&P Mid-Cap ETF | 3.56% | 5,330,070 | 169.66M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 3.32% | 4,979,416 | 158.49M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 2.76% | 4,132,775 | 131.55M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 2.41% | 3,604,513 | 114.73M | Jun 29, 2026 |